A Safety and Efficacy Study Evaluating CTX130 in Subjects With Relapsed or Refractory T or B Cell Malignancies (COBALT-LYM) Read more about A Safety and Efficacy Study Evaluating CTX130 in Subjects With Relapsed or Refractory T or B Cell Malignancies (COBALT-LYM)
EARLY TAVR: Evaluation of TAVR Compared to Surveillance for Patients With Asymptomatic Severe Aortic Stenosis Read more about EARLY TAVR: Evaluation of TAVR Compared to Surveillance for Patients With Asymptomatic Severe Aortic Stenosis
Expanded Access Request Program for Belantamab Mafodotin (GSK2857916) in Multiple Myeloma Read more about Expanded Access Request Program for Belantamab Mafodotin (GSK2857916) in Multiple Myeloma
Comparison of Anticoagulation With Left Atrial Appendage Closure After AF Ablation Read more about Comparison of Anticoagulation With Left Atrial Appendage Closure After AF Ablation
TTX-030 Single Agent and in Combination With Immunotherapy or Chemotherapy for Patients With Advanced Cancers Read more about TTX-030 Single Agent and in Combination With Immunotherapy or Chemotherapy for Patients With Advanced Cancers
Safety and Efficacy of ALLO-501 Anti-CD19 Allogeneic CAR T Cells in Adults With Relapsed/Refractory Large B Cell or Follicular Lymphoma Read more about Safety and Efficacy of ALLO-501 Anti-CD19 Allogeneic CAR T Cells in Adults With Relapsed/Refractory Large B Cell or Follicular Lymphoma
First Line Radiofrequency Ablation Versus Antiarrhythmic Drugs for Persistent Atrial Fibrillation Treatment (RAAFT-3) Read more about First Line Radiofrequency Ablation Versus Antiarrhythmic Drugs for Persistent Atrial Fibrillation Treatment (RAAFT-3)
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial Read more about Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
Pulsed Field Ablation to Irreversibly Electroporate Tissue and Treat AF Read more about Pulsed Field Ablation to Irreversibly Electroporate Tissue and Treat AF
The SQUID Trial for the Embolization of the Middle Meningeal Artery for Treatment of Chronic Subdural Hematoma (STEM) Read more about The SQUID Trial for the Embolization of the Middle Meningeal Artery for Treatment of Chronic Subdural Hematoma (STEM)